07630.HK
Impact Therap-b
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 15.59
+4.07%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- -HKD 0.33
- Revenue estimate
- HKD 186.1M
Latest reported
- Last report date
- Aug 31, 2026
- EPS actual
- -HKD 0.05
- EPS estimate
- -HKD 0.04
- Revenue actual
- HKD 15.5M
- Revenue estimate
- HKD 144.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -48.0%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027